Drug intelligence / Profile preview

DNK-FLU

Development stage: Unknown
Lead developer: Denka Seiken
Modality: Vaccines & Immunotherapeutics
Administration: Subcutaneous

Overview

DNK-FLU is Denka Seiken's egg-derived, inactivated split-virion trivalent influenza hemagglutinin vaccine developed for prevention of influenza. The formulation used in the DNK-PEDFLU-2 pediatric study contained hemagglutinin antigens from A/California/7/2009 (H1N1)pdm, A/Victoria/210/2009 (H3N2), and B/Brisbane/60/2008, each at not less than 30 micrograms/mL as hemagglutinin protein. It is administered by subcutaneous injection and induces strain-specific humoral immunity, including hemagglutination-inhibiting and virus-neutralizing antibodies. The development program supported the Japanese products Flu-Syringe Seiken and Influenza HA Vaccine Seiken. ([pmda.go.jp](https://www.pmda.go.jp/drugs/2011/P201100137/47003800_16100EZZ01207_K100_1.pdf))

Brand names: Flu-Syringe SeikenFlu-シリンジ「生研」Influenza HA Vaccine SeikenインフルエンザHAワクチン「生研」
Other names: DNK FLU

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on DNK-FLU.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNK-FLU.

Explore the full profile